Search Results

Filter Results

Reset filters

Date

All Dates

Past 7 Days 1

Past 30 Days 6

Past year 97

Custom range

Custom Date Range

Start date: End date:

Topic

All Topics

Medicare 843

Insurance 570

Health Industry 555

Cost and Quality 513

The Health Law 375

States 344

Aging 305

Health Care Costs 299

Medicaid 237

Public Health 221

Pharmaceuticals 127

Multimedia 98

Courts 80

Elections 68

COVID-19 62

Capitol Desk 60

California 55

Uninsured 54

Rural Health 47

Mental Health 45

Noticias En Español 43

Navigating Aging 37

Race and Health 21

Health Care Reform 14

Medi-Cal 7

Asking Never Hurts 6

Global Health Watch 4

Covered California 3

Postcards 2

HealthBent 2

KFF Health News Impact 0

Spotlight 0

KFF Health News On Air 0

The New Old Age 0

Audio Report 0

Content Type

All Content Types

Morning Briefing 598

Podcast 62

Story 885

Showing 301-320 of 1,562 results for "medicare advantage"

Sort by Relevance Date

KFF Health News' 'What the Health?': Alabama’s IVF Ruling Still Making Waves

February 29, 2024 Podcast

Lawmakers in Congress and state legislatures are scrambling to react to the ruling by the Alabama Supreme Court that frozen embryos created for in vitro fertilization are legally children. Abortion opponents are divided among themselves, with some supporting full “personhood” for fertilized eggs, while others support IVF as a moral way to have children. Rachel Cohrs of Stat, Riley Griffin of Bloomberg News, and Joanne Kenen of the Johns Hopkins University schools of nursing and public health and Politico Magazine join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews University of Pittsburgh law professor Greer Donley, who explains how a 150-year-old anti-vice law that’s still on the books could be used to ban abortion nationwide. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.

X
Facebook
LinkedIn
Email
Print

Officials Spotlight Abuses Of Medicare Advantage Coding

May 19, 2022 Morning Briefing

The coding process in private Medicare plan options need to be reformed, former and current officials have said, noting that health insurers’ use of coding to get higher payments is a problem. Also: Cerebral replaces its CEO, patient risks from ransomware attacks, and more.

X
Facebook
LinkedIn
Email
Print

Patent Battle Over Generic Versions Of Gilead HIV Drug Settled

September 13, 2022 Morning Briefing

Five drugmakers had proposed generic versions of Gilead’s HIV and hepatitis B drugs and are now licensed to sell them from around 2031 onward. Also in the news: Medicare advantage star ratings, and more.

X
Facebook
LinkedIn
Email
Print

Gaps In Maternity Care Are Widening Across The US: Report

October 11, 2022 Morning Briefing

Stat covers an upcoming March of Dimes report that says 2% more American counties are categorized as maternity care “deserts” since the 2020 report. Problems for Centene’s expansion of Medicare Advantage, details on the CommonSpirit Health hack, and more are in the news.

X
Facebook
LinkedIn
Email
Print

After Appalachian Hospitals Merged Into a Monopoly, Their ERs Slowed to a Crawl

By Brett Kelman and Samantha Liss March 25, 2024 KFF Health News Original

Ballad Health was granted the nation’s largest state-sanctioned hospital monopoly in 2018. Since then, its emergency rooms have become more than three times as slow.

X
Facebook
LinkedIn
Email
Print

3 States Limit Nursing Home Profits in Bid to Improve Care

By Susan Jaffe October 25, 2021 KFF Health News Original

Following the devastating impact of covid-19 on nursing homes, state lawmakers want to be sure that government and private payments primarily go to improve care and staffing.

X
Facebook
LinkedIn
Email
Print

KFF Health News' 'What the Health?': As US Bumps Against Debt Ceiling, Medicare Becomes a Bargaining Chip

January 19, 2023 Podcast

The debt ceiling crisis facing Washington puts Medicare and other popular entitlement programs squarely on the negotiating table this year as newly empowered Republicans demand spending cuts. Meanwhile, as more Americans than ever have health insurance, the nation’s health care workforce is straining under the load. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Tami Luhby of CNN, and Victoria Knight of Axios join KHN’s chief Washington correspondent Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

X
Facebook
LinkedIn
Email
Print

KFF Health News' 'What the Health?': Debt Deal Leaves Health Programs (Mostly) Intact

June 7, 2023 Podcast

The bipartisan deal to extend the U.S. government’s borrowing authority includes future cuts to federal health agencies, but they are smaller than many expected and do not touch Medicare and Medicaid. Meanwhile, Merck & Co. becomes the first drugmaker to sue Medicare officials over the federal health insurance program’s new authority to negotiate drug prices. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Lauren Weber of The Washington Post, and Jessie Hellmann of CQ Roll Call join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News senior correspondent Sarah Jane Tribble, who reported the latest KFF Health News-NPR “Bill of the Month” feature, about the perils of visiting the U.S. with European health insurance.

X
Facebook
LinkedIn
Email
Print

KHN’s ‘What the Health?’: Delta Blues

August 5, 2021 KFF Health News Original

Covid is back with a vengeance, with some people clamoring for booster shots while others harden their resistance to getting vaccinated at all. Meanwhile, the Food and Drug Administration is pushing hard on drugmaker Pfizer’s request to upgrade the emergency authorization for its vaccine and give it final approval. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite health policy stories of the week they think you should read, too.

X
Facebook
LinkedIn
Email
Print

Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge

By Arthur Allen May 7, 2024 KFF Health News Original

The FDA told Amgen to test whether a quarter-dose of its lung cancer drug worked as well as the amount recommended on the product label. It did and with fewer side effects. But Amgen is sticking to the higher dose — which earns it an additional $180,000 a year per patient.

X
Facebook
LinkedIn
Email
Print

‘Injections, Injections, Injections’: Troubling Questions Follow Closure of Sprawling Pain Clinic Chain

By Anna Maria Barry-Jester and Jenny Gold February 22, 2022 KFF Health News Original

In May 2021, Lags Medical Centers, one of California’s largest chains of pain clinics, abruptly closed its doors amid a cloaked state investigation. Nine months later, patients are still in the dark about what happened with their care and to their bodies.

X
Facebook
LinkedIn
Email
Print

A stethoscope atop hundred-dollar bills on a flat surface.

Why Many Nonprofit (Wink, Wink) Hospitals Are Rolling in Money

By Elisabeth Rosenthal July 29, 2024 KFF Health News Original

Legal maneuvering, industry lobbying, and lax IRS oversight leave lots of room for “operating surpluses.”

X
Facebook
LinkedIn
Email
Print

KFF Health News' 'What the Health?': Judging the Abortion Pill

March 16, 2023 Podcast

Any day now a conservative federal judge in Texas could upend the national abortion debate by requiring the FDA to rescind its approval of mifepristone, a drug approved in the U.S. more than 20 years ago that is now used in more than half of abortions nationwide. Meanwhile, a controversial study on masks gets a clarification, although it may be too late to change the public impression of what it found. Alice Miranda Ollstein of Politico, Jessie Hellmann of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.

X
Facebook
LinkedIn
Email
Print

KFF Health News' 'What the Health?': A Health-Heavy State of the Union

February 9, 2023 Podcast

President Joe Biden’s 2023 State of the Union address leaned heavily on health care issues. Biden took a victory lap for recent accomplishments like capping prescription drug costs for seniors on Medicare. He also urged Congress to make permanent the boosted premium subsidies under the Affordable Care Act, and he sparred with Republicans on threats to cut Social Security and Medicare. Also this week, both sides in the abortion debate are bracing for a court decision out of Texas that could, at least temporarily, make the abortion pill mifepristone illegal nationwide. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Kate Baicker of the University of Chicago about a possible middle ground in the effort to get universal health insurance coverage.

X
Facebook
LinkedIn
Email
Print

A close-up of a pharmacist scanning a prescription.

When Copay Assistance Backfires on Patients

By Julie Appleby March 15, 2024 KFF Health News Original

Drugmakers offer copay assistance programs to patients, but insurers are tapping into those funds, not counting the amounts toward patient deductibles. That leads to unexpected charges. But the practice is under growing scrutiny.

X
Facebook
LinkedIn
Email
Print

Clarity on Covid Count: Pandemic’s Toll on Seniors Extended Well Beyond Nursing Homes

By Judith Graham August 6, 2021 KFF Health News Original

The latest research shows that although deaths in nursing homes received enormous attention, far more older adults who perished from covid lived outside of institutions. People with dementia and other severe neurological conditions, chronic kidney disease and immune deficiencies were hit especially hard.

X
Facebook
LinkedIn
Email
Print

Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers

By Rachana Pradhan August 8, 2023 KFF Health News Original

Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.

X
Facebook
LinkedIn
Email
Print

Dentists Chip Away at Uninsured Problem by Offering Patients Membership Plans

By Phil Galewitz September 17, 2021 KFF Health News Original

The plans are designed for people who don’t get dental coverage through their jobs and can’t afford an individual plan. For about $300 to $400 a year, patients receive certain preventive services at no charge and other procedures at a discount.

X
Facebook
LinkedIn
Email
Print

Medicare Advantage Plans Too Often Deny Care, HHS Watchdog Reports

April 29, 2022 Morning Briefing

The inspector general’s office urged HHS officials to increase oversight of the private insurance plans.

X
Facebook
LinkedIn
Email
Print

Inflation To Impact Negotiations Between Health Providers, Insurers

June 29, 2022 Morning Briefing

Modern Healthcare warns negotiations between health providers and insurers may be “bloody” thanks to the impact of inflation, which rose for general goods more than health care in May. Separately, Medicare Advantage is chastised by government watchdogs for denying care and overcharging.

X
Facebook
LinkedIn
Email
Print

More From KFF Health News

In Rush To Satisfy Trump, GOP Delivers Blow to Health Industry

Health and Human Services Secretary Robert F. Kennedy Jr. speaking in a House of Representatives hearing room. He is also seen on a screen behind him broadcasting the hearing.

Vested Interests. Influence Muscle. At RFK Jr.’s HHS, It’s Not Pharma. It’s Wellness.

A photo of a die-in staged at a statehouse.

Who’s Policing Opioid Settlement Spending? A Crowdsourced Database Might Help

Journalists Tally State and Local Health Care Implications of GOP Megabill